Platelet-activating protamine-heparin-antibodies lead to higher protamine demand in patients undergoing cardiac surgery

Journal of Thoracic and Cardiovascular Surgery

Volumn 150, Issue 4, 2015, Pages 967-973.e1

  Grieshaber, Philippe ^a   Bakchoul, Tamam ^b   Wilhelm, Jochen ^c   Wagner, Alexander ^a   Wollbrück, Matthias ^a   Böning, Andreas ^a   Sachs, Ulrich ^a  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

^c JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

Author keywords

41.1; CTSNet classification 37

Indexed keywords

ANTIBODY; BLOCKING ANTIBODY; FC RECEPTOR IIA; HEPARIN; PROTAMINE; PROTAMINE HEPARIN COMPLEX ANTIBODY; UNCLASSIFIED DRUG; ANTICOAGULANT AGENT; HEPARIN ANTAGONIST;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD SAMPLING; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; FEMALE; HEART SURGERY; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOEMBOLISM; BLOOD; IMMUNOLOGY;

AGED; ANTIBODIES; ANTICOAGULANTS; CARDIOPULMONARY BYPASS; FEMALE; HEPARIN; HEPARIN ANTAGONISTS; HUMANS; MALE; PLATELET ACTIVATION; PROSPECTIVE STUDIES; PROTAMINES;

EID: 84942837459     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2015.07.057     Document Type: Article

References (22)

1. R.L. Kanippayoor, J.H. Alpern, and A.J. Moehring Protamines and spermatogenesis in Drosophila and Homo sapiens Spermatogenesis 3 2013 e24376 Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3710222/ Accessed April 27, 2013
2. M. Yavari, and R.C. Becker Anticoagulant therapy during cardiopulmonary bypass J Thromb Thrombolysis 26 2008 218 228
3. T. Heise, U. Eckers, K. Kanc, J.N. Nielsen, and L. Nosek The pharmacokinetic and pharmacodynamic properties of different formulations of biphasic insulin aspart: a randomized, glucose clamp, crossover study Diabetes Technol Ther 10 2008 479 485
4. I.A. Michaels, and P.G. Barash Hemodynamic changes during protamine administration Anesth Analg 62 1983 831 835
5. M.E. Weiss, and N.F. Adkinson Jr. Allergy to protamine Clin Rev Allergy 9 1991 339 355
6. J.M. Weiler, M.A. Gellhaus, J.G. Carter, R.L. Meng, P.M. Benson, R.A. Hottel, and et al. A prospective study of the risk of an immediate adverse reaction to protamine sulfate during cardiopulmonary bypass surgery J Allergy Clin Immunol 85 1990 713 719
7. H. Al-Mondhiry, W.S. Pierce, and R.M. Basarab Protamine-induced thrombocytopenia and leukopenia Thromb Haemost 53 1985 60 64
8. A. Cuker, and D.B. Cines Protamine-induced thrombocytopenia? Blood 121 2013 2818 2819
9. S.L. Chudasama, B. Espinasse, F. Hwang, R. Qi, M. Joglekar, G. Afonina, and et al. Heparin modifies the immunogenicity of positively charged proteins Blood 116 2010 6046 6053
10. T. Bakchoul, H. Zöllner, J. Amiral, S. Panzer, S. Selleng, T. Kohlmann, and et al. Anti-protamine-heparin antibodies: incidence, clinical relevance, and pathogenesis Blood 121 2013 2821 2827
11. T. Samuel, A.H. Kolk, and P. Rümke Studies on the immunogenicity of protamines in humans and experimental animals by means of a micro-complement fixation test Clin Exp Immunol 33 1978 252 260
12. G.M. Lee, I.J. Welsby, B. Phillips-Bute, T.L. Ortel, and G.M. Arepally High incidence of antibodies to protamine and protamine/heparin complexes in patients undergoing cardiopulmonary bypass Blood 121 2013 2828 2835
13. C. Pouplard, D. Leroux, J. Rollin, J. Amiral, M.A. May, and Y. Gruel Incidence of antibodies to protamine sulfate/heparin complexes in cardiac surgery patients and impact on platelet activation and clinical outcome Thromb Haemost 109 2013 1141 1147
14. A. Singla, M.J. Sullivan, G. Lee, J. Bartholomew, S. Kapadia, R.H. Aster, and et al. Protamine-induced immune thrombocytopenia Transfusion (Paris) 53 2013 2158 2163
15. A. Greinacher, I. Michels, V. Kiefel, and C. Mueller-Eckhardt A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia Thromb Haemost 66 1991 734 736
16. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Available at: http://www.R-project.org. Accessed March 3, 2015.
17. Bates D, Maechler M, Bolker B, Walker S, Christensen RHB, Singmann H, et al. lme4: Linear mixed-effects models using Eigen and S4. Available at: http://cran.r-project.org/web/packages/lme4/index.html. Accessed March 3, 2015.
18. Kuznetsova A, Brockhoff PB, Christensen RHB. lmerTest: Tests in linear mixed effects models. Available at: http://cran.r-project.org/web/packages/lmerTest/index.html. Accessed March 3, 2015.
19. Lenth RV, Hervé M. lsmeans: least-squares means. Available at: http://cran.r-project.org/web/packages/lsmeans/index.html. Accessed March 3, 2015.
20. A.B. Kurtz, R.S. Gray, S. Markanday, and J.D. Nabarro Circulating IgG antibody to protamine in patients treated with protamine-insulins Diabetologia 25 1983 322 324
21. J.A. Ellerhorst, J.P. Comstock, and L.J. Nell Protamine antibody production in diabetic subjects treated with NPH insulin Am J Med Sci 299 1990 298 301
22. P. Subramaniam, P. Skillington, and J. Tatoulis Heparin-rebound in the early postoperative phase following cardiopulmonary bypass Aust N Z J Surg 65 1995 331 333